Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-12-21

FDA Approved: LORATADINE — Original Application (Bionpharma Inc.)

View source ↗

Summary

The FDA approved Bionpharma Inc.'s original ANDA for loratadine, authorizing a generic loratadine product to be marketed in the United States.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Loratadine (Loratadine)

Snippet

ORIG AP for LORATADINE (LORATADINE)